203 related articles for article (PubMed ID: 686527)
1. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized BCG (Tice strain) treatment of bronchogenic carcinoma: phase I study.
Cusumano CL; Jernigan JA; Waldman RH
J Natl Cancer Inst; 1975 Aug; 55(2):275-9. PubMed ID: 169370
[TBL] [Abstract][Full Text] [Related]
3. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
[TBL] [Abstract][Full Text] [Related]
4. BCG immunostimulation in primary pulmonary cancer (a clinical, immunological and radiological study).
Dénes L; Büttner K; Galambos G; Krasznai G
Dev Biol Stand; 1986; 58 ( Pt A)():425-32. PubMed ID: 3297874
[TBL] [Abstract][Full Text] [Related]
5. [Survival of patients with planocellular bronchial carcinoma who were treated conservatively and with surgery].
Nagorni-Obradović L
Med Pregl; 1993; 46(11-12):429-33. PubMed ID: 7997199
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
7. Intralesional injection of BCG using the fibreoptic bronchoscope in the treatment of bronchogenic carcinoma.
Millar JW; Hunter AM; Wightman AJ; Horne NW
Eur J Respir Dis; 1980 Jun; 61(3):162-6. PubMed ID: 7439279
[TBL] [Abstract][Full Text] [Related]
8. Non-specific immunostimulation in bronchogenic cancer.
Israel L
Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
[No Abstract] [Full Text] [Related]
9. Care of the patient with inoperable lung cancer.
Carr DT
Clin Notes Respir Dis; 1973; 12(1):3-12. PubMed ID: 4350114
[No Abstract] [Full Text] [Related]
10. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
11. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
[No Abstract] [Full Text] [Related]
12. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
13. [Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer].
Decroix G; Chastang C; Lebeau B; Fabre C; Lepage T; Rebishung JL; Babo P; Fichet D; Soubrane C; Asselain B
Rev Mal Respir; 1984; 1(1):25-30. PubMed ID: 6379784
[TBL] [Abstract][Full Text] [Related]
14. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic experience in lung cancer using BCG cell-wall skeleton--with special reference to cases of pleural effusion].
Morishita M
Kekkaku; 1977 Oct; 52(10):531-2. PubMed ID: 599772
[No Abstract] [Full Text] [Related]
16. Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma.
Millar JW; Roscoe P; Pearce SJ; Ludgate S; Horne NW
Thorax; 1982 Jan; 37(1):57-60. PubMed ID: 7041323
[TBL] [Abstract][Full Text] [Related]
17. Bronchogenic carcinoma associated with upper aerodigestive cancers.
Yellin A; Hill LR; Benfield JR
J Thorac Cardiovasc Surg; 1986 May; 91(5):674-83. PubMed ID: 3702476
[TBL] [Abstract][Full Text] [Related]
18. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bronchogenic carcinoma with surgery and radiotherapy: the experience of the National Cancer Institute of Milan.
Bucalossi P; Ravasi G; Bozzetti F; Milani F
Cancer Chemother Rep 3; 1973 Mar; 4(2):101-7. PubMed ID: 4729313
[No Abstract] [Full Text] [Related]
20. Serum immunoglobulin levels and survival rates in bronchogenic carcinoma patients.
Plesnicar S; Rudolf Z
Neoplasma; 1979; 26(6):721-8. PubMed ID: 542209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
